HALIFAX, NS / ACCESSWIRE / January 9, 2025 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announced that its received investigational testing authorization (ITA) from Health Canada to begin clinical trial ...

HALIFAX, NS / ACCESSWIRE / / Today, MedMira Inc. (MedMira) (TSXV:MIR) announced that its received investigational testing ...

Bora Biologics, a division of CDMO Bora Pharmaceuticals, will support DotBio, a biopharmaceutical company specializing in ...

Alloy Therapeutics ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug discovery technologies, announced today that it is launching a new ...

Samsung Biologics has extended its collaboration with LigaChem Biosciences for antibody-drug conjugate (ADC) services. The ...

Samsung Biologics, a global contract development and manufacturing organization (CDMO), has extended its collaboration with ...

Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, announced the licensing of its fully human antibodies to SOTIO Biotech, a ...

Under the agreement, Ailux Biologics grants UCB a non-exclusive license to leverage XtalFold™ for the discovery and ...

NanoImaging Services ("NIS"), the leading provider of cryo-electron microscopy ("cryo-EM") services for drug discovery and ...

PD-1 x VEGF antibodies show potential to surpass checkpoint inhibitors as standard-of-care in multiple oncology indications• NAYA aiming to ...

NIH Researchers Discover Novel Class of Anti-Malaria Antibodies - New Antibodies Could Lead to Generation of Interventions ...